Insulin aspart, recombinant Subcutaneous and Thrombate III
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Thrombate III and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: antithrombin iii
Brand name: Thrombate III
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Thylox Acne Treatment Topical
- Insulin aspart, recombinant Subcutaneous-Thymoglobulin
- Insulin aspart, recombinant Subcutaneous-Thymoglobulin rabbit
- Insulin aspart, recombinant Subcutaneous-Thyrogen
- Insulin aspart, recombinant Subcutaneous-Thyroid
- Insulin aspart, recombinant Subcutaneous-Thyroid desiccated
- Thrombate III-Insulin degludec
- Thrombate III-Insulin Degludec (U-100) Prefilled Pens
- Thrombate III-Insulin Degludec (U-100) Vials
- Thrombate III-Insulin Degludec (U-200) Prefilled Pens
- Thrombate III-Insulin degludec and liraglutide
- Thrombate III-Insulin degludec and liraglutide Subcutaneous